Kazia Therapeutics Ltd ADR
Price & Volume
Stats
See more52W Range | $2.86-$39.05 |
Market Cap | $11.6M |
Shares Short | 15,790 |
Financials
See moreRevenue (12 Mos) | $2.5M |
Revenue Growth (YoY) | 557,150% |
Gross Profit (12 Mos) | $2.5M |
Diluted EPS | -$29.43 |
News
See moreYahoo Finance • last month
Discover the top movers in Thursday's pre-market session.
Yahoo Finance • 2 years ago
KAZIA'S PAXALISIB RECEIVES FAST TRACK DESIGNATION FROM FDA FOR TREATMENT OF SOLID TUMOR BRAIN METASTASES HARBORING PI3K PATHWAY MUTATIONS IN COMBINATION WITH RADIATION THERAPY
Yahoo Finance • 3 years ago
KAZIA PRESENTS NEW DATA FOR PAXALISIB AND EVT801 AT AACR ANNUAL MEETING
About
Address | Three International Towers, Sydney, NSW, Australia, 2000 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |
